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Summary
Background: Skin disorders are common in travelers. Knowledge of the relative frequency of
post-travel-related skin disorders, including their geographic and demographic risk factors, will
allow for effective pre-travel counseling, as well as improved post-travel diagnosis and ther-
apeutic intervention.
Methods: We performed a retrospective study using anonymous patient demographic, clinical,
and travel-related data from the GeoSentinel Surveillance Network clinics from January 1997
through February 2006. The characteristics of these travelers and their itineraries were analyzed
using SAS 9.0 statistical software.
Results: A skin-related diagnosis was reported for 4594 patients (18% of all patients seen in a
GeoSentinel clinic after travel). The most common skin-related diagnoses were cutaneous larva
migrans (CLM), insect bites including superinfected bites, skin abscess, and allergic reaction (38%
of all diagnoses). Arthropod-related skin diseases accounted for 31% of all skin diagnoses. Ill§ The views expressed in this article are those of the authors and do not reflect the official policy or position of the funding agency, Centers for
Disease Control and Prevention, the Department of the Navy, or the Department of Defense. This study was presented in part as an oral
presentation at the 52nd Annual Meeting of the American Society of Tropical Medicine and Hygiene, Philadelphia, USA, December 3—7, 2003,
abstract No. 775.
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travelers who visited countries in the Caribbean experienced the highest proportionate morbidity
due to dermatologic conditions. Pediatric travelers had significantly more dog bites and CLM and
fewer insect bites compared with their adult counterparts; geriatric travelers had proportionately
more spotted fever and cellulitis.
Conclusions: Clinicians seeing patients post-travel should be alert to classic travel-related skin
diseases such as CLM as well as moremundane entities such as pyodermas and allergic reactions. To
prevent and manage skin-related morbidity during travel, international travelers should avoid
direct contact with sand, soil, and animals and carry a travel kit including insect repellent, topical
antifungals, and corticosteroids and, in the case of extended and/or remote travel, an oral
antibiotic with ample coverage for pyogenic organisms.
Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.Introduction
Skin disorders are among the six most common reasons
returned travelers seek medical care;1—3 potentially, 10%
of travel-related skin conditions may be serious enough to
lead to hospitalization.4 Skin conditions develop as a result of
a variety of factors: stressors of travel (including exposure to
new medications), extremes of temperature and humidity,
exposure to plant or animal toxins, infection with a local
organism, or medical problems unrelated to travel, such as
malignancy. Skin conditions may be associated with the
length of stay and environmental risk factors. Travelers
who choose to stay only in urban centers in first-class accom-
modation for brief periods are much less likely to acquire an
‘exotic’ skin disorder, whereas those living with locals in rural
areas for prolonged stays are potentially at greater risk.
Certain conditions, such as Buruli ulcers, are frequent in
indigenous populations in Sub-Saharan Africa, but are
exceedingly rare in the returned traveler;5 at the other
extreme, in some areas, cutaneous larva migrans (CLM)
may represent up to 25% of the skin lesions seen in travelers.4
Prospective cohort studies,4 chart reviews,6 and case ser-
ies7 have been published in an effort to analyze skin conditions
in travelers but have shown inconsistent findings or have been
relatively small in scale.7 Large-scale incidence data have not
beenpreviouslypublished.Oneof the larger reviewsevaluated
fewer than 3000 travelers; 772 complained of medical pro-
blems, 3% of whom had a dermatologic complaint.8
As of March 1, 2006, the GeoSentinel Surveillance Network
provided a denominator of over 50 000 patient encounters
from 31 travel and/or tropical disease clinics around the
world. The multicenter composition of the database ensures
a heterogeneous representation of travel destinations, ori-
gins, and categories of ill returned travelers. These data
provide an excellent reference point from which to approach
pre-travel risk assessment and preparation concerning the
prevention of skin disorders in the traveler. In addition, they
will enable the clinician, whether an emergency room phy-
sician or a travel medicine specialist, to better formulate a
post-travel differential diagnosis, direct appropriate diag-
nostic resources, and institute efficacious, timely therapy.
Methods
Data source
GeoSentinel is a global sentinel surveillance network estab-
lished in 1995 through a cooperative agreement between theInternational Society for Travel Medicine (ISTM) and the
Centers for Disease Control and Prevention (CDC) in Atlanta,
USA.9 It is composed of 31 globally dispersed physician-based
travel/tropical medicine clinics chosen for their experience
and training in travel and tropical medicine.10 To be eligible
for entry into the GeoSentinel database, patients must have
crossed an international border within 10 years before seek-
ing medical advice for a presumed travel-related illness or
have been referred for a post-travel screening examination.
The sites accounting for the majority of patient intake are
within academic centers; several smaller-volume sites
(almost all with current academic affiliation) are in free-
standing locations. The intake at sites reflects a mixed
population of tertiary care and self-referred patients. Some
sites are restricted to outpatients, and no site has its entire
practice limited to ill returned travelers.
Data collected include demographic data (age, sex, birth
country, country of residence, and country of current citizen-
ship) and travel history. Travel history includes more detailed
itineraries for travel within 6 months of a GeoSentinel clinic
visit, a record of all countries visited in the 5 years before the
visit, and any relevant countries visited if the likely exposure
was more than 5 years ago. All countries are categorized into
one of 15 regions of the world. Depending upon the itinerary,
multiple countries may have been recorded for a single trip.
Other data recorded include the reason for most recent
travel, major reasons for patient encounter (including skin
problem), whether the patient reported receiving pre-travel
health advice, most likely place of exposure, and setting of
patient interaction (e.g., inpatient). The healthcare provider
selects a final diagnosis(es) from a list of over 500 diagnoses
and assesses the certainty of each diagnosis selected. All sites
use the best available reference diagnostics in their own
country. All information is entered anonymously into a cen-
tral web-based SQL database.
Inclusion criteria
Data entered into the GeoSentinel database from January
1997 through February 2006 were reviewed. Only patients
seen after travel, with a confirmed or probable final diagnosis
were included; only returned travelers were included (i.e.,
immigrants, current expatriates, and travelers-in-transit
were excluded). Patients were considered to have a derma-
tologic diagnosis if they had one of 63 possible diagnostic
codes or if they had one of 36 diagnoses for which a skin
manifestation is not an essential component, but had skin
symptoms as a primary reason for seeking care (e.g., uncom-
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diagnoses, onchocerciasis, loiasis, allergic reaction). Derma-
tologic diagnoses were divided into diagnostic categories
that pertained to a possible source of exposure or etiology.
These categories included trauma-induced, arthropod-
borne, fungal, allergic, animal-related, soil-related,
water-borne, food-borne, pyodermas, human exposure,
pre-existing illness that may be exacerbated by travel, tem-
perature exposure, and unknown.
Statistical analysis
The relative frequency of dermatologic diagnoses and their
association with patient demographic and travel character-
istics were analyzed using SAS version 9.0 (SAS Institute).
Country-specific proportionate dermatology morbidity is
defined as the number of patients with a subset of derma-
tologic diagnoses after travel to the country as a proportion
of all ill returned travelers to the country with skin disease.
Statistical significance for crude analysis of dichotomous
variables was determined by the use of Chi-square test or
Fisher’s exact test with calculation of odds ratios (OR).
Regional multivariate logistic regressions were employed
to evaluate factors potentially associated with being diag-
nosed with a dermatologic condition relative to being diag-
nosed with another condition.
Results
A skin-related diagnosis was reported for 4594 patients (18%
of all visits recorded at a GeoSentinel clinic after travel);
since some individuals were diagnosed with more than one
dermatologic condition, a total of 4742 diagnoses were
recorded. A comparison of demographics, itinerary charac-
teristics, clinical queries, and region of travel between
travelers presenting with a dermatologic condition versus
all other reasons to seek post-travel medical care is pre-
sented in Table 1. Patients with dermatologic diagnoses were
more likely to have traveled in Southeast Asia and the
Americas and less likely to have traveled in Africa and South
Central Asia than were patients with other types of diag-
noses. The results of multivariate logistic regression by
region for these same variables are presented in Table 2.
Based on the multivariate models, results that were both
statistically significant and clinically significant showed that,
although there were regional differences, travelers given a
dermatologic diagnosis had greater odds of being younger
(<18 years of age), traveling for tourism purposes, and
presenting to a healthcare provider within a week of return,
and lower odds of having fever, having a pre-travel health
encounter, and traveling on a long itinerary (>8 weeks)
relative to travelers with other diagnoses.
Characteristics of travelers with the ten most frequent
dermatologic diagnoses and several other diagnoses of spe-
cial interest are presented in Table 3. CLM, insect bites, and
skin abscess were the three most frequent diagnoses; rash of
unknown etiology comprised only 5.5% of all skin diagnoses.
Travelers less than 18 years of age were more likely to be
diagnosed with CLM and dog bites and less likely to be
diagnosed with insect bites, dengue, or spotted fever group
rickettsiae. In contrast, travelers over 65 years of age weremore likely to have spotted fever group rickettsiae or cellu-
litis and less likely to have CLM or dengue. In comparison with
their male counterparts, a greater proportion of female
travelers were diagnosed with insect bites or an allergic rash
whereas a smaller proportion of females were diagnosed with
skin abscess or leishmaniasis. In the following countries, one
disease entity accounted for greater than one third of all
dermatologic diagnoses: CLM (Barbados, Jamaica), leishma-
niasis (Bolivia), spotted fever group rickettsiae (Zimbabwe,
South Africa), and myiasis (Belize). Countries of exposure
with the highest overall proportion of morbidity attributable
to dermatologic diagnoses were Barbados, Belize, Jamaica,
and Bolivia. The diagnoses with the greatest percentage of
individuals traveling on long itineraries (>8 weeks) were
leishmaniasis (61%), scabies (42%), and rash of unknown
etiology (40%); 32% of travelers presenting with a dog bite
were traveling on brief itineraries (<8 days).
In an attempt to quantify the exposures/etiologies
responsible for travel-related dermatologic diagnoses,
Table 4 outlines the dermatologic diagnoses by category.
Arthropod-related diagnoses are by far the most common
(30.9%); diagnoses of unknown etiology and pyodermas com-
prise 14.6% and 12.8%, respectively.
Discussion
Dermatologic conditions are common in the returned traveler
and were recognized during 18% of visits in ill returning
travelers at GeoSentinel Network clinics. This is consistent
with previous reports from the GeoSentinel Network10 but
higher than the 8—9% reported in other prospective studies of
returned travelers2 and travelers in transit.11 The current
study represents the largest retrospective series of travelers
presenting with dermatologic conditions reported in the
literature. Compared with the largest prospective series
from a French clinic (N = 269) by Caumes et al.,4 demographic
characteristics are very similar. Consistent with our findings,
Caumes et al. reported that over 75% of their patients were
returning from tourism-related travel.4 Both series report a
good deal of overlap in the most frequent diagnoses, includ-
ing insect bites, pyodermas, and CLM. Several differences are
worth noting, however. GeoSentinel patients traveled pro-
portionately more in Asia, whereas the Caumes series had a
greater percentage returning from Africa and the Caribbean.
Furthermore, tungiasis was much less frequent in our series
(only 31 diagnoses of 4742). In addition, Caumes et al. con-
cluded that 53% of their patients had a classical tropical
disease (e.g., CLM, myiasis, leishmaniasis, dengue), whereas
only 24% of our patients did. The higher frequency in Caumes’
study is likely due to their inclusion of travelers only return-
ing from ‘tropical countries’, whereas the GeoSentinel Net-
work includes travelers returning from temperate regions
(Table 1); furthermore, since the patients in Caumes’ series
were referred from healthcare providers, those with more
mundane conditions may not have been referred.
There were significant relationships between dermatolo-
gical diagnoses and demographic and clinical characteristics
of the ill returned travelers; due to the large sample size of
this dataset, most variables in the univariate analysis
(Table 1) were statistically significant. Therefore, we focus
our discussion on the findings of the multivariate analysis
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Table 1 Basic characteristics: ill returned travelers with a dermatologic diagnosis vs. all other patients in the GeoSentinel
Surveillance Network databasea
Ill returned travelers
with skin disease (N = 4594)
All other ill returned
travelers (N = 20 326)
Demographics b
Age <18 years 6.0% (277) 4.3% (868)
Age 18—65 years 88.9% (4085) 91.2% (18 543)
Age >65 years 4.7% (214) 3.9% (791)
Female 49.6% (2280) 47.1% (9578)
Region of travel
Southeast Asia 18.7% (857) 14.0% (2837)
Sub-Saharan Africa 18.0% (825) 26.4% (5376)
South America 13.3% (612) 8.9% (1815)
South central Asia 11.3% (517) 13.7% (2786)
Central America 9.4% (434) 7.1% (1433)
Caribbean 8.7% (401) 5.3 % (1069)
Western Europe 4.1% (187) 3.1% (630)
North Africa 2.9% (132) 4.4% (898)
Other regions, including multiplec 13.7% (629) 17.1% (3482)
Clinical characteristics
Fever 12.1% (556) 31.5% (6401)
Inpatient 5.7% (260) 10.3% (2094)
Pre-travel encounter 49.0% (2249) 53.2% (10 816)
Purpose of travel
Tourism 69.1% (3175) 56.1% (11 409)
Business 10.4% (477) 14.9% (3036)
Research/education 3.9% (178) 4.4% (890)
Missionary/volunteer 5.5% (253) 9.2% (1865)
Visiting friends/relatives 10.9% (500) 15.0% (3040)
Travel duration
<2 weeks 23.2% (1064) 21.2% (4303)
2—8 weeks 35.3% (1620) 32.9% (6679)
>8 weeks 27.6% (1267) 33.9% (6883)
Time to HCP visit
<8 days 33.8% (1554) 29.4% (5985)
8—35 days 31.0% (1424) 29.5% (6006)
>35 days 32.6% (1496) 38.4% (7796)
HCP = healthcare provider.
a Missing data: age (142), sex (385), fever (0), inpatient (900), pre-travel encounter (314), purpose of travel (97), travel duration (3104),
time to HCP visit (659).
b p-Value calculated by Chi-square test was statistically significant (i.e., p < 0.05) for all variables except time to HCP visit (8—35 days) and
purpose of travel (research/education).
c Other regions include East Asia, Australia/New Zealand, Eastern Europe, Oceania, Antarctica, multiple regions, and cruise ship/airport/
airplane.(Table 3). There was a significantly higher number of children
in our series when compared with all GeoSentinel travelers.
This might in part be explained because CLM was the most
frequent dermatologic diagnosis and the risk of CLM is asso-
ciated with skin exposure to sand, whether on a beach or in a
sandbox.12 Travelers less than 18 years of age, who may be
more likely to have barefoot exposure to sand, were indeed
more likely to be diagnosed with CLM. The greater proportion
of ill travelers presenting to a healthcare provider within one
week of their returnmay have resulted from a combination of
the short CLM incubation period (median of 8 days in the
Caumes study) and a variety of other relatively acute con-
ditions (pyodermas, arthropod and animal bites) for whichtravelers might be expected to have sought healthcare
urgently. Febrile returned travelers in this study were rare,
since the majority of dermatologic conditions are not classi-
cally associated with fever (e.g., CLM, arthropod bite, aller-
gic rash, superficial fungal infection).
The Caribbean region, including countries that border the
Caribbean (i.e., Belize), has a strikingly high proportionate
morbidity due to dermatologic diagnoses, yet is associated
with the least amount of pre-travel counseling (Table 2) as
well as a shorter length of travel, suggesting missed oppor-
tunities for the dissemination of prevention messages. As
exposed skin is at greater risk for arthropod bites, solar
damage, parasite infiltration, and contact with irritants
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Table 2 Basic characteristics of ill returned travelers with a dermatologic diagnosis vs. all other patients in the GeoSentinel Surveillance Network database: odds ratio point
estimates (95% confidence intervals) for variables used in the multivariate regression models for selected regions of travel
Southeast
Asia (n = 857)
Sub-Saharan
Africa (n = 825)
South America
(n = 612)
South Central
Asia (n = 517)
Central America
(n = 434)
Caribbean
(n = 401)
Western Europe
(n = 187)
North Africa
(n = 132)
Demographics
Age <18 years NS 1.54 (1.12—2.12) NS 1.90 (1.24—2.91) NS 2.30 (1.43—3.69) 2.29 (1.18—4.45) 2.96 (1.72—5.09)
Age 18—65 yearsa
Age >65 years NS 1.93 (1.36—2.73) NS NS NS NS NS NS
Female NS NS 0.69 (0.57—0.84) NS NS NS NS NS
Clinical characteristics
Fever (yes) 0.25 (0.21—0.31) 0.26 (0.22—0.32) 0.17 (0.12—0.25) 0.42 (0.33—0.54) 0.29 (0.20—0.42) 0.22 (0.15—0.33) 0.28 (0.15—0.52) 0.40 (0.23—0.68)
Inpatient (yes) NS NS 1.79 (1.16—2.74) NS NS NS NS NS
Pre-travel
encounter (no)
1.31 (1.10—1.56) NS NS NS NS 1.84 (1.43—2.38) NS 1.61 (1.10—2.34)
Reason for travel
Tourisma
Business 0.60 (0.45—0.80) 0.65 (0.52—0.81) 0.56 (0.41—0.78) NS 0.36 (0.22—0.59) NS NS NS
Research/education NS NS NS NS 0.44 (0.26—0.75) NS NS NS
Missionary/volunteer 0.44 (0.27—0.70) 0.70 (0.55—0.90) 0.25 (0.18—0.35) NS 0.26 (0.17—0.41) NS NS NS
Visiting friends/
relatives (VFR)
NS 0.70 (0.56—0.86) 0.64 (0.47—0.86) NS 0.45 (0.27—0.74) 0.28 (0.17—0.47) NS NS
Travel duration
<2 weeks NS NS NS NS NS NS NS NS
2—8 weeksa
>8 weeks 0.77 (0.63—0.94) 0.61 (0.51—0.72) NS 0.81 (0.66-0.99) NS 0.66 (0.48—0.92) NS NS
Time to HCP visit
<8 days 1.22 (1.01—1.47) NS NS 1.37 (1.13—1.67) NS 1.61 (1.22—2.11) NS NS
8—35 daysa
>35 days 0.63 (0.51—0.77) NS 0.79 (0.65—0.97) NS 0.61 (0.48—0.77) NS 0.40 (0.28—0.57) 0.56 (0.37—0.84)
NS = not statistically significant.
Multiple logistic regressions performed for each region with n > 100.
Explanatory variables in regression analysis included inpatient status, fever, age, sex, reason for travel, duration, time to presentation, pre-travel consultation.
a Reference group for non-dichotomous variables.
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Table 3 Ten most frequent diagnoses and additional diagnoses of interest — comparison with all ill returned travelers with dermatologic diagnoses
Diagnosis (n) % of all
dermatologic
diagnoses
% Female % Pediatric
(age 0—17)
% Geriatric
(age > 65)
Country-specific
proportionate
morbidity (fraction)b
% with
pre-travel
encounter
Primary reasons
for travel (%)c
Travel duration
% <2 weeks
% >8 weeks
All (4742) 100 50 6.0 4.7 Barbados (39/65) 49 Tourism (69) 23
Belize (49/85) VFR (11) 28
Jamaica (81/146)
Bolivia (105/227)
CLM (465) 9.8 48 9.9a 2.0a Barbados (29/39)
Jamaica (44/81)
Malaysia (13/42)
44a Tourism (87) 25
Business (4) 19a
Insect bite (388) 8.2 62a 3.1a 6.5 USA (12/54) 50 Tourism (77) 28a
Peru (13/68) Business (9) 15a
Costa Rica (17/105)
Skin abscess (366) 7.7 43a 3.9 3.3 Madagascar (9/35) 58a Tourism (69) 14a
Kenya (14/85)
Philippines (13/84)
VFR (11) 32a
Superinfected insect
bite (324)
6.8 54 6.2 3.1 Sri Lanka (24/121) 63a Tourism (79) 13a
South Africa (16/115) VFR (10) 15a
Thailand (43/468)
Allergic rash (263) 5.5 62a 6.1 2.3 Dominican Republic (12/98) 58a Tourism (67) 18
India (25/268) Business (15) 23
Brazil (16/222)
Rash, unknown
etiology (262)
5.5 52 4.2 6.9 Mexico (11/150) 52 Tourism (69) 24
Brazil (15/222) Business (10) 40a
India (11/268)
Dog bite (203) 4.3 47 12.0a 3.0 China (15/44) 38a Tourism (69) 32a
Vietnam (10/49) VFR (15) 16a
Thailand (46/468)
Superficial fungal
infection (190)
4.0 45 5.8 2.1 Sri Lanka (7/121) 59a Tourism (56) 14a
Thailand (18/468) MV (16) 37a
Brazil (9/222)
Dengue (159) 3.4 48 1.3a 0.6a Indonesia (13/120)
Thailand (33/468)
57 Tourism (64) 29
India (18/268) Business (13) 23
Leishmaniasis (158) 3.3 34a 8.3 7.0 Bolivia (52/105) 61a Tourism (63) 15a
Costa Rica (13/105) RE (11) 61a
Peru (7/68)
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y.and allergens, travel to regions where travelers are apt to be
scantily clad naturally will pose a greater risk for dermato-
logic conditions. For some distinct clinical entities such as
CLM and leishmaniasis, a high proportion of the reported
morbidity was associated with travel to a small number of
countries. This finding is in stark contrast to diagnoses such as
rash of unknown etiology, superficial fungal infection, and
cellulitis, which are unlikely to be associated with a parti-
cular country/region or a memorable exposure. While these
data do not imply that travelers to other countries are not at
risk for these diagnoses, knowledge of disease entity/country
pairs with high proportionate morbidity provides a unique
opportunity for healthcare providers to offer special pre-
travel counseling regarding appropriate preventive mea-
sures.
The large base of travelers in the GeoSentinel Network
allows for a more detailed analysis of dermatologic diagnoses
too rare for most single clinics to perform. For example, we
compared 158 cases of cutaneous leishmaniasis with those in
three other series.13—15 In all series, including our own,
leishmaniasis was associated with a male predominance
and a long duration of travel. Central and South American
countries (particularly Bolivia) were frequently reported as
the place of exposure in all series, including our own. Madidi
National Park, a popular tourist destination in Bolivia,
emerged as a leading site of exposure in the Scope series14
as well as our own. For myiasis, the mean age and median
length of stay in the one heterogeneous series16 were quite
similar for our dataset (data not shown). The series by Tamir
et al. consisted of young Israeli tourists, most of whom had
returned from Madidi National Park in Bolivia.17 In our study,
although fewer ill travelers had been to Belize than Bolivia,
myiasis morbidity as a proportion of all dermatologic mor-
bidity for Belize was twice that of Bolivia. Unlike the results
of our study, in which the sex ratio was almost equal for both
New World and Old World cutaneous myiasis (data not
shown), other case series have reported a predominance
of females16,18,19 contracting Dermatobia hominis in the
New World, but male predominance for patients infected
with Cordylobia anthropophaga16 in the Old World. This
difference could be due to the small sample size in other
case series or a change in demographics of travelers at risk.
Over 200 dog bites are reported in our series, the greatest
proportionate morbidity of which can be attributed to China,
Vietnam, and Thailand. Children had a greater likelihood of
presenting with a dog bite. In numerous non-travel related
scenarios, children have been noted to be at higher risk for
dog bites,20,21 especially in the head and neck area,22 loca-
tions that are known risk factors for rapid progression of
rabies infection.23 The GeoSentinel Network has thoroughly
reviewed this topic elsewhere.24 Since spotted fever rick-
ettsial diagnoses include many separate entities with a wide
geographic distribution it would be difficult to compare these
cases with other reports in the literature. However, these
datamay indicate that older individuals are at greater risk for
presenting with spotted fever; this may be related to the
greater disposable income and leisure time required for many
African safari itineraries.
Knowledge about risks due to particular exposures/etiol-
ogies can provide a basis for prevention strategies. Due to the
preponderance of arthropod-related disease, the use of
insect repellant cannot be stressed enough for the prevention
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Table 4 Composition of disease categories
Disease category (most frequent diagnoses under that category in rank order) All dermatologic diagnoses
N = 4742 (100%)
Arthropod-related (insect bite, insect bite (superinfected),
dengue, cutaneous leishmaniasis)
1466 (30.9%)
Unknown (rash, unknown etiology, urticaria, pruritus
of unknown etiology)
694 (14.6%)
Pyodermas (skin abscess, cellulitis, erysipelas) 609 (12.8%)
Soil-related (CLM, tungiasis) 496 (10.5%)
Animal-related (dog bite, monkey bite, bite — other animal) 439 (9.3%)
Allergic in nature (allergic rash, allergic reaction) 263 (5.5%)
Human to human (scabies, leprosy, syphilis, varicella) 233 (4.9%)
Fungal origin (fungal rash, superficial fungal infection) 211 (4.4%)
Endogenous (HSV, herpes zoster, psoriasis) 129 (2.7%)
Trauma-related (laceration, contusion) 68 (1.4%)
Water-borne (marine bite/sting, sea-bathers eruption) 64 (1.3%)
Drug-related (drug-related rash, non-mefloquine adverse reaction) 42 (0.9%)
Temperature-related (frostbite, sunburn) 21 (0.4%)
Food-borne (cutaneous/subcutaneous cysticercosis) 7 (0.1%)
CLM = cutaneous larva migrans; HSV = herpes simplex virus.of both dermatologic conditions as well as life threatening
travel-related illness caused by malaria and arboviruses.25 In
our series, pyodermas comprised nearly 13% of dermatologic
diagnoses, findings similar to a recent study by Ansart et al.,
which found that 21% of dermatoses in returned travelers
were due to pyodermas.26 For extended and/or remote
itineraries, travel kits should include a topical antibiotic
(e.g., mupirocin) for self-treatment of early lesions, as well
as an oral antibiotic with staphylococcal/streptococcal cov-
erage for self-treatment of a more extensive pyoderma.
Given the rise in drug-resistant bacteria (e.g., methicillin-
resistant Staphylococcus aureus—MRSA) in many parts of the
world, travelers should be counseled to seek medical care
urgently should self-treatment of a pyoderma fail. In addi-
tion, given the high frequency of this condition, practitioners
should stress attention to personal hygiene, especially in the
setting of arthropod bites and trauma. Soil and animal-
related conditions each accounted for approximately 10%
of diagnoses. A pre-travel focus on the use of proper footwear
(especially for Caribbean vacations) and avoidance of ani-
mals, both wild and domestic (particularly in Asia), should be
emphasized; interestingly, both travelers at risk for animal
bites as well as CLM are among the least likely to have pre-
travel consultation. Our study also suggests that animal bites
are not limited to individuals traveling on a longer itinerary;
likewise, Gautret et al. found no distinction in length of
itinerary among travelers who sustain animal bites during
travel.24 Therefore, it may be worthwhile to consider pre-
exposure rabies vaccination for travelers on shorter itiner-
aries destined for remote areas of Asia with high propor-
tionate morbidity for animal bites (e.g., China, Vietnam,
Thailand).
Several limitations of this study are noteworthy. First,
since the GeoSentinel Network represents a sample of ill
travelers, the incidence and risk of returning with any given
diagnosis cannot be calculated. However, proportionate mor-
bidity, or the ratio of ill travelers with a subset of diagnoses to
all ill returned travelers for a given country can be calculatedto compare relative frequencies of illness in ill returned
travelers.
Second, the authors acknowledge that most travel med-
icine physicians are not dermatologists and therefore the
accuracy of some diagnoses may be in question. However, our
results reflect the types of illnesses severe enough for
returned travelers to seek care at a site known for expertise
in travel/tropical medicine. Many of the most frequent
diagnoses (e.g., CLM, skin abscess, dog bite, myiasis, leish-
maniasis) have classical appearances and the accuracy of
these diagnoses is likely to be quite high in light of the
extensive experience of travel medicine specialists in our
network. Many dermatological conditions are self-limited
and so may have resolved before a clinic visit or confirmation
of the etiology was possible. To reduce the uncertainty of
diagnoses, we selected only patients with diagnoses that
were confirmed or probable. In spite of this approach,
5.3% of cases were deemed ‘rash, unknown etiology’, a
reasonable number under these circumstances. By compar-
ison, in the Caumes study, 3.3% of patients were classified as
‘undetermined’ and 4.1% as ‘rash and fever’.4 It is interesting
to note that travelers seen with rash of unknown etiology had
a greater likelihood of being on an itinerary of greater than 8
weeks. This duration may be an indication of the complexity
of the itinerary (i.e., multiple countries) or simply of the
increased time interval between the exposure and the clinic
visit; both may contribute to recall bias and a failure to
recount important exposures responsible for the condition.
There is also a limited ability to recall patients for additional
history or diagnostics because of the limitations of insurance,
manpower, and patient willingness.
Third, since our patients are reported through a sentinel
travel/tropical medicine surveillance network, patients who
sought care elsewhere (i.e., at a non-specialized or primary
care practice or with a dermatologist) on return are not
included. Data also would not be captured if the traveler
were treated successfully abroad or if their lesions had
resolved before medical care was sought. Hill reported that
Dermatologic conditions of the ill returned traveler 6017% of his travel cohort sought care for a dermatologic con-
dition during travel.2
In summary, dermatologic conditions are common in
travelers and were found in 18% of ill returned travelers
seen at a GeoSentinel Network site; CLM, skin abscess, and
arthropod bites were the three most common diagnoses. Ill
travelers who visited countries in the Caribbean experi-
enced the highest proportionate morbidity due to derma-
tologic conditions. Many dermatologic conditions related to
travel could be prevented by consistently applying arthro-
pod repellent, wearing closed shoes, maintaining good skin
hygiene, and avoiding feral and domesticated animals.
Pediatric travelers have increased odds of returning with
a dermatologic condition. Children require parental super-
vision to ensure prevention measures are properly
employed, especially with regards to contact with soil/sand
and animals. Travel kits should include diethyltoluamide
(DEET)-based arthropod repellent, low dose topical corti-
costeroid, and antifungal cream, as well as instructions for
the proper indication and use of all contents. Oral as well as
topical antibiotics against staphylococcal/streptococcal
infections should be provided for remote and/or prolonged
itineraries where self-treatment by travelers may be
necessary.
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